University of Perigia Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2003
NCT00951574
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Alternative names

Internal and Vascular Medicine University of Perigia (Italy)

Active Ingredients

Drugs in Phase 3 Trials (2)

nadroparin (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Thromboembolism (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2